Behçet's Syndrome in a Child: A Case Report and a Review of Literature

被引:0
作者
Alatyan, Muzun H. [1 ]
Albahouth, Hind S. [1 ]
Fahad, Mogabh S. Al [1 ]
Alotaibi, Lama A. [1 ]
Almutairi, Ebtihal S. [1 ]
Almalky, Hadeel A. [1 ]
Faden, Asmaa A. [1 ]
机构
[1] King Saud Univ, Dent, Riyadh, Saudi Arabia
关键词
beh & ccedil; et's syndrome in children; joint pain; colchicine; hla-b51/b5; recurrent oral ulcers; BEHCETS-DISEASE; CLASSIFICATION CRITERIA;
D O I
10.7759/cureus.67273
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Beh & ccedil;et's syndrome is a complex chronic inflammatory disorder characterized by widespread inflammation of the blood vessels, affecting various systems in the body. Although its exact cause remains unknown, genetic predisposition, particularly HLA-B51/B5 gene carriage, and environmental factors are believed to play roles. The disease typically manifests in individuals aged 20-40 years, with an uncommon occurrence in children and elderly individuals. Key clinical manifestations include recurrent oral and genital ulcers, skin lesions, ocular involvement, positive pathergy test results, and other systemic symptoms. Eye involvement is common and can lead to severe visual impairment if left untreated. This diversity of Beh & ccedil;et's disease (BD) presentations and complications emphasizes the importance of early recognition and management. An eight-year-old girl presented with a deep painful ulcer in the mouth and a history of chronic constipation, severe joint pain, and recurrent mouth ulcers. Initial examination revealed an ulcer scar on the tongue and a deep ulcer on the left side of the mucobuccal fold. The patient was diagnosed with a recurrent major aphthous ulcer and prescribed Predo pediatric syrup as a mouthwash and paracetamol to relieve the pain. A biopsy was recommended by her physician to be done under general anesthesia and to rule out malignancy; the biopsy result revealed the presence of a benign squamous epithelium with reactive changes. The genetic result revealed HLA B*51 positivity and normal immunoglobulin levels. Treatment with colchicine led to the complete healing of the ulcer with scar formation after three months. This case report highlights the unique presentation of Beh & ccedil;et's syndrome in children and the challenges associated with its diagnosis. It emphasizes the importance of the early recognition and prompt management of BD in the pediatric population, in which disease progression can be more severe than in adult-onset cases. This case provides valuable insights into the clinical features of and diagnostic approach to Beh & ccedil;et's syndrome in children.
引用
收藏
页数:7
相关论文
共 20 条
[1]  
Adil A., 2023, BEHCET DIS
[2]   Update on the Diagnosis of Behcet's Disease [J].
Alibaz-Oner, Fatma ;
Direskeneli, Haner .
DIAGNOSTICS, 2023, 13 (01)
[3]  
Batu ED, 2017, CLIN EXP RHEUMATOL, V35, pS119
[4]   The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria [J].
Davatchi, F. ;
Assaad-Khalil, S. ;
Calamia, K. T. ;
Crook, J. E. ;
Sadeghi-Abdollahi, B. ;
Schirmer, M. ;
Tzellos, T. ;
Zouboulis, C. C. ;
Akhlagi, M. ;
Al-Dalaan, A. ;
Alekberova, Z. S. ;
Ali, A. A. ;
Altenburg, A. ;
Arromdee, E. ;
Baltaci, M. ;
Bastos, M. ;
Benamour, S. ;
Ben Ghorbel, I. ;
Boyvat, A. ;
Carvalho, L. ;
Chen, W. ;
Ben-Chetrit, E. ;
Chams-Davatchi, C. ;
Correia, J. A. ;
Crespo, J. ;
Dias, C. ;
Dong, Y. ;
Paixao-Duarte, F. ;
Elmuntaser, K. ;
Elonakov, A. V. ;
Grana Gil, J. ;
Haghdoost, A-A. ;
Hayani, R. M. ;
Houman, H. ;
Isayeva, A. R. ;
Jamshidi, A. R. ;
Kaklamanis, P. ;
Kumar, A. ;
Kyrgidis, A. ;
Madanat, W. ;
Nadji, A. ;
Namba, K. ;
Ohno, S. ;
Olivieri, I. ;
Vaz Patto, J. ;
Pipitone, N. ;
de Queiroz, M. V. ;
Ramos, F. ;
Resende, C. ;
Rosa, C. M. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (03) :338-347
[5]   Current concepts in the etiology and treatment of Behcet disease [J].
Evereklioglu, C .
SURVEY OF OPHTHALMOLOGY, 2005, 50 (04) :297-350
[6]  
Fresko I, 2005, CLIN EXP RHEUMATOL, V23, pS67
[7]   Standard and novel therapeutic approaches to Behcet's disease [J].
Gul, Ahmet .
DRUGS, 2007, 67 (14) :2013-2022
[8]   HLA-B*51 and Behcet Disease [J].
Gul, Ahmet ;
Ohno, Shigeaki .
OCULAR IMMUNOLOGY AND INFLAMMATION, 2012, 20 (01) :37-43
[9]   2018 update of the EULAR recommendations for the management of Behcet's syndrome [J].
Hatemi, Gulen ;
Christensen, Robin ;
Bang, Dongsik ;
Bodaghi, Bahram ;
Celik, Aykut Ferhat ;
Fortune, Farida ;
Gaudric, Julien ;
Gul, Ahmet ;
Koetter, Ina ;
Leccese, Pietro ;
Mahr, Alfred ;
Moots, Robert ;
Ozguler, Yesim ;
Richter, Jutta ;
Saadoun, David ;
Salvarani, Carlo ;
Scuderi, Francesco ;
Sfikakis, Petros P. ;
Siva, Aksel ;
Stanford, Miles ;
Tugal-Tutkun, Ilknur ;
West, Richard ;
Yurdakul, Sebahattin ;
Olivieri, Ignazio ;
Yazici, Hasan .
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (06) :808-818
[10]   Demographic and clinical properties of juvenile-onset Behcet's disease: A controlled multicenter study [J].
Karincaoglu, Yelda ;
Borlu, Murat ;
Toker, Sernra Cikman ;
Akman, Ayse ;
Onder, Meltem ;
Gunasti, Suhan ;
Usta, Aysegul ;
Kandi, Basak ;
Durusoy, Cicek ;
Seyhan, Muammer ;
Utas, Serap ;
Saricaoglu, Hayriye ;
Ozden, Muge Guler ;
Uzun, Soner ;
Tursen, Umit ;
Cicek, Demet ;
Donmez, Levent ;
Alpsoy, Erkan .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (04) :579-584